30787593|t|Neuroprotective potential of ketamine prevents developing brain structure impairment and alteration of neurocognitive function induced via isoflurane through the PI3K/AKT/GSK-3beta pathway.
30787593|a|BACKGROUND: The aim of the current experimental study was to scrutinize the neuroprotective effect of ketamine on the isoflurane (iso)-induced cognitive dysfunction in rats via phosphoinositide 3 kinase (PI3K)/protein kinase B (AKT)/glycogen synthase kinase 3beta (GSK-3beta) pathway. MATERIALS AND METHODS: Sprague-Dawley rats were used for the current experimental study. The rats were divided into six groups and rats were treated with ketamine and memantine. For the estimation of cognitive function study, we used the Morris water test. Pro-inflammatory cytokines such as IL-1beta, IL-6, tumor necrosis factor-alpha (TNF-alpha), and caspase-6; the antioxidant parameters malondialdehyde, glutathione, superoxide dismutase, catalase, and protein carbonyl; acetylcholinesterase, amyloid beta, and brain-derived neurotrophic factor were estimated, respectively. The protein expression of AKT, GSK-3beta, p21WAF1/CIP1, and p53 was also estimated, respectively. RESULTS: Ketamine significantly enhanced cognitive function and showed anti-inflammatory and antioxidant effects, and exhibited the neuroprotective effect of ketamine against the isoflurane-induced cognitive impairment. Additionally, ketamine significantly (P<0.005) suppressed IL-1beta, TNF-alpha, IL-6, caspase-6 and p21WAF1/CIP1, p53 expression and up-regulated the PI3K/AKT/GSK-3beta expression in the group of iso-induced rats. CONCLUSION: We can conclude that ketamine prevented the cognitive impairment induced by isoflurane anesthesia through anti-apoptotic, anti-inflammatory, and antioxidant effects via the PI3K/AKT/GSK-3beta pathway.
30787593	29	37	ketamine	Chemical	MESH:D007649
30787593	58	84	brain structure impairment	Disease	MESH:D001927
30787593	139	149	isoflurane	Chemical	MESH:D007530
30787593	167	170	AKT	Gene	24185
30787593	171	180	GSK-3beta	Gene	84027
30787593	292	300	ketamine	Chemical	MESH:D007649
30787593	308	318	isoflurane	Chemical	MESH:D007530
30787593	320	323	iso	Chemical	MESH:D007530
30787593	333	354	cognitive dysfunction	Disease	MESH:D003072
30787593	358	362	rats	Species	10116
30787593	367	392	phosphoinositide 3 kinase	Gene	85243
30787593	418	421	AKT	Gene	24185
30787593	423	453	glycogen synthase kinase 3beta	Gene	84027
30787593	455	464	GSK-3beta	Gene	84027
30787593	513	517	rats	Species	10116
30787593	568	572	rats	Species	10116
30787593	606	610	rats	Species	10116
30787593	629	637	ketamine	Chemical	MESH:D007649
30787593	642	651	memantine	Chemical	MESH:D008559
30787593	736	748	inflammatory	Disease	MESH:D007249
30787593	767	775	IL-1beta	Gene	24494
30787593	777	781	IL-6	Gene	24498
30787593	783	810	tumor necrosis factor-alpha	Gene	24835
30787593	812	821	TNF-alpha	Gene	24835
30787593	828	837	caspase-6	Gene	83584
30787593	866	881	malondialdehyde	Chemical	MESH:D008315
30787593	883	894	glutathione	Chemical	MESH:D005978
30787593	918	926	catalase	Gene	24248
30787593	950	970	acetylcholinesterase	Gene	83817
30787593	990	1023	brain-derived neurotrophic factor	Gene	24225
30787593	1080	1083	AKT	Gene	24185
30787593	1085	1094	GSK-3beta	Gene	84027
30787593	1104	1108	CIP1	Gene	114851
30787593	1114	1117	p53	Gene	301300
30787593	1161	1169	Ketamine	Chemical	MESH:D007649
30787593	1228	1240	inflammatory	Disease	MESH:D007249
30787593	1310	1318	ketamine	Chemical	MESH:D007649
30787593	1331	1341	isoflurane	Chemical	MESH:D007530
30787593	1350	1370	cognitive impairment	Disease	MESH:D003072
30787593	1386	1394	ketamine	Chemical	MESH:D007649
30787593	1430	1438	IL-1beta	Gene	24494
30787593	1440	1449	TNF-alpha	Gene	24835
30787593	1451	1455	IL-6	Gene	24498
30787593	1457	1466	caspase-6	Gene	83584
30787593	1479	1483	CIP1	Gene	114851
30787593	1485	1488	p53	Gene	301300
30787593	1526	1529	AKT	Gene	24185
30787593	1530	1539	GSK-3beta	Gene	84027
30787593	1567	1570	iso	Chemical	MESH:D007530
30787593	1579	1583	rats	Species	10116
30787593	1618	1626	ketamine	Chemical	MESH:D007649
30787593	1641	1661	cognitive impairment	Disease	MESH:D003072
30787593	1673	1683	isoflurane	Chemical	MESH:D007530
30787593	1724	1736	inflammatory	Disease	MESH:D007249
30787593	1775	1778	AKT	Gene	24185
30787593	1779	1788	GSK-3beta	Gene	84027
30787593	Negative_Correlation	MESH:D007530	MESH:D007649
30787593	Positive_Correlation	MESH:D007530	MESH:D001927
30787593	Negative_Correlation	MESH:D007649	MESH:D001927
30787593	Association	MESH:D007249	24498
30787593	Association	MESH:D007530	84027
30787593	Association	MESH:D007530	24185
30787593	Negative_Correlation	MESH:D007649	24494
30787593	Positive_Correlation	MESH:D007649	24185
30787593	Positive_Correlation	MESH:D007649	84027
30787593	Association	MESH:D007249	24494
30787593	Association	MESH:D003072	84027
30787593	Positive_Correlation	MESH:D007530	MESH:D003072
30787593	Negative_Correlation	MESH:D007649	114851
30787593	Negative_Correlation	MESH:D007649	MESH:D003072
30787593	Negative_Correlation	MESH:D007649	301300
30787593	Association	24185	84027
30787593	Negative_Correlation	MESH:D007649	83584
30787593	Negative_Correlation	MESH:D007649	24835
30787593	Association	MESH:D007249	83584
30787593	Negative_Correlation	MESH:D007649	MESH:D007249
30787593	Negative_Correlation	MESH:D007649	24498
30787593	Association	MESH:D003072	24185
30787593	Association	MESH:D007249	24835

